Evaluation of salivary alpha-amylase as a potential biomarker of inhaled β
2
-agonist response
Ann Allergy Asthma Immunol
.
2023 May;130(5):664-665.
doi: 10.1016/j.anai.2023.01.032.
Epub 2023 Feb 3.
Authors
Andrea A Pappalardo
1
,
Jun Fu
2
,
James N Moy
3
Affiliations
1
Departments of Medicine and Pediatrics, University of Illinois at Chicago, Chicago, Illinois.
2
Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois.
3
Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois. Electronic address: jmoy@rush.edu.
PMID:
36738784
DOI:
10.1016/j.anai.2023.01.032
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers
Humans
Saliva
Salivary alpha-Amylases*
Substances
Salivary alpha-Amylases
Biomarkers